Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19

Ravindra Ganesh, Colin Pawlowski, John C. O’Horo, Lori L. Arndt, Richard Arndt, Sarah J. Bell, Dennis M. Bierle, Molly Destro Borgen, Sara N. Hanson, Alexander Heyliger, Jennifer J. Larsen, Patrick Lenehan, Robert Orenstein, Arjun Puranik, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, AJ Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley, Raymund R. Razonable
doi: https://doi.org/10.1101/2021.05.23.21257670

Data Availability

Data referred to in the manuscript is maintained by the authors and available upon request

Back to top
Posted May 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
Ravindra Ganesh, Colin Pawlowski, John C. O’Horo, Lori L. Arndt, Richard Arndt, Sarah J. Bell, Dennis M. Bierle, Molly Destro Borgen, Sara N. Hanson, Alexander Heyliger, Jennifer J. Larsen, Patrick Lenehan, Robert Orenstein, Arjun Puranik, Leigh L. Speicher, Sidna M. Tulledge-Scheitel, AJ Venkatakrishnan, Caroline G. Wilker, Andrew D. Badley, Raymund R. Razonable
medRxiv 2021.05.23.21257670; doi: https://doi.org/10.1101/2021.05.23.21257670
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area